HI
CRL icon

Harbour Investments’s Charles River Laboratories CRL Stock Holding History

Harbour Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4K Buy
134
+12
+10% +$2.14K ﹤0.01% 2692
2026
Q1 		$21K Buy
122
+71
+139% +$13.2K ﹤0.01% 2860
2025
Q4 		$10.2K Sell
51
-1
-2% -$181 ﹤0.01% 2736
2025
Q3 		$8.14K Buy
52
+2
+4% +$318 ﹤0.01% 2783
2025
Q2 		$7.59K Sell
50
-6
-11% -$800 ﹤0.01% 2692
2025
Q1 		$8.43K Sell
56
-4
-7% -$671 ﹤0.01% 2601
2024
Q4 		$11.1K Hold
60
– – ﹤0.01% 2399
2024
Q3 		$11.8K Buy
60
+10
+20% +$2.08K ﹤0.01% 2283
2024
Q2 		$10.3K Buy
50
+20
+67% +$4.53K ﹤0.01% 2250
2024
Q1 		$8.13K Buy
30
+1
+3% +$239 ﹤0.01% 2300
2023
Q4 		$6.86K Sell
29
-9
-24% -$1.77K ﹤0.01% 2299
2023
Q3 		$7.45K Sell
38
-3
-7% -$616 ﹤0.01% 2143
2023
Q2 		$8.62K Sell
41
-15
-27% -$2.98K ﹤0.01% 2101
2023
Q1 		$11.3K Sell
56
-9
-14% -$2.04K ﹤0.01% 1961
2022
Q4 		$14.2K Buy
65
+14
+27% +$3.06K ﹤0.01% 1812
2022
Q3 		$11K Hold
51
– – ﹤0.01% 1880
2022
Q2 		$11K Buy
+51
New +$12.5K ﹤0.01% 1880
2021
Q4 		$14K Sell
36
-119
-77% -$46.2K ﹤0.01% 1795
2021
Q3 		$64K Buy
155
+32
+26% +$13.3K ﹤0.01% 1616
2021
Q2 		$46K Sell
123
-23
-16% -$7.68K ﹤0.01% 1860
2021
Q1 		$42K Buy
+146
New +$40.6K ﹤0.01% 1786

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Harbour Investments's CRL Position: Q2 2026 in Review

Harbour Investments increased its Charles River Laboratories (CRL) stake by 9.8% in Q2 2026, buying an estimated $2.14K and bringing the position to 134 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Harbour Investments first reported a position in CRL in Q1 2021 and has held it in 21 quarters since. The position peaked at $64K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Harbour Investments held 134 shares of Charles River Laboratories worth $30.4K as of Q2 2026.
  • Harbour Investments bought 12 Charles River Laboratories shares in Q2 2026, an estimated $2.14K.
  • Charles River Laboratories made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2692 holding.
  • Harbour Investments first reported a position in Charles River Laboratories in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Charles River Laboratories position peaked at $64K in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.